Biocept provides a secure physician portal to access patient reports. Additionally, resources are available for review.
Biocept consistently captures circulating tumor cells (CTCs) in patients with early-stage, metastatic or recurrent cancer. We offer laboratory tests for Enumeration and HER2 (FISH).
Biocept has entered into collaborations with several academic institutions and pharmaceutical or biotech companies to explore the application of the CEE system to research CTCs.